These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6191727

  • 1. Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs.
    Vemulapalli S, Chiu PJ.
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):109-23. PubMed ID: 6191727
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J, Rigter B, Földes-Filep E.
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC, Zimmerman BG, Kraft E, Kounenis G, Friedman P.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [Abstract] [Full Text] [Related]

  • 4. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE, Gillespie JB.
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [Abstract] [Full Text] [Related]

  • 5. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH, Anderson WP, Johnston CI.
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [Abstract] [Full Text] [Related]

  • 6. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y, Miura K, Imanishi M, Yukimura T, Komori T, Okahara T, Yamamoto K.
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [Abstract] [Full Text] [Related]

  • 7. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S, Kher V, Scicli AG, Beierwaltes WH, Carretero OA.
    Hypertension; 1983 Jul; 5(6):893-9. PubMed ID: 6197374
    [Abstract] [Full Text] [Related]

  • 8. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.
    Miura K, Abe Y, Yamamoto K.
    J Pharmacol Exp Ther; 1982 Jul; 222(1):246-50. PubMed ID: 6177851
    [Abstract] [Full Text] [Related]

  • 9. Blood pressure and renin responses to captopril in anesthetized rats pretreated with indomethacin or aprotinin.
    Kusaba-Suzuki M, Satoh S.
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):292-302. PubMed ID: 2420298
    [Abstract] [Full Text] [Related]

  • 10. [Studies on the mechanism of action of angiotensin converting enzyme inhibitors on the dog kidney].
    Omosu M.
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):883-94. PubMed ID: 1484407
    [Abstract] [Full Text] [Related]

  • 11. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
    Walker LA, Gellai M, Valtin H.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
    [Abstract] [Full Text] [Related]

  • 12. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K, Minato H, Nakatsuji K, Suzuki H, Nose I, Oka M, Hosoki K, Hatano N, Kadokawa T.
    Arzneimittelforschung; 1986 Mar; 36(1):69-73. PubMed ID: 3513779
    [Abstract] [Full Text] [Related]

  • 13. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M, Stewart JM, Vavrek RJ, Nasjletti A.
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [Abstract] [Full Text] [Related]

  • 14. Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril, on the cardiovascular, endocrine, and renal responses to furosemide in conscious lambs.
    de Wildt SN, Smith FG.
    Can J Physiol Pharmacol; 1997 Apr; 75(4):263-70. PubMed ID: 9196851
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of captopril-induced renal vasodilatation in anesthetized dogs after nonhypotensive hemorrhage.
    Wong PC, Zimmerman BG.
    J Pharmacol Exp Ther; 1980 Oct; 215(1):104-9. PubMed ID: 7005423
    [Abstract] [Full Text] [Related]

  • 16. Effects of captopril on the renal hemodynamics during aprotinin infusion in anesthetized dogs.
    Mizumura Y, Matsumoto M, Nishino A, Takata M, Iida H, Sugimoto T.
    Ren Physiol; 1984 Oct; 7(5):299-303. PubMed ID: 6207570
    [Abstract] [Full Text] [Related]

  • 17. Indirect evidence against a role of the kinin system in the renal hemodynamic effect of captopril in the rat.
    Mimran A, Casellas D, Dupont M.
    Kidney Int; 1980 Dec; 18(6):746-53. PubMed ID: 7009958
    [Abstract] [Full Text] [Related]

  • 18. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
    Abels BC, Branch RA, Sabra R.
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1285-92. PubMed ID: 8450463
    [Abstract] [Full Text] [Related]

  • 19. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat.
    Jaffa AA, Vio CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF, Mayfield RK.
    J Clin Invest; 1992 May; 89(5):1460-8. PubMed ID: 1373739
    [Abstract] [Full Text] [Related]

  • 20. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG, Goering JL, Raich PC.
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.